Comparison

Erlotinib-d6 European Partner

Item no. HY-50896S-1ea
Manufacturer MedChem Express
CASRN 1034651-23-4
Amount 1 ea
Quantity options 1 ea 1 mg 5 mg
Category
Type Inhibitor
Specific against other
Citations [1]Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997, 57(21), 4838-4848.
Smiles [2H]C([2H])([2H])OCCOC1=CC2=NC=NC(NC3=CC=CC(C#C)=C3)=C2C=C1OCCOC([2H])([2H])[2H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias CP-358774-d6,NSC 718781-d6,OSI-774-d6
Shipping Condition Room temperature
Available
Manufacturer - Type
Isotope-Labeled Compounds
Manufacturer - Applications
Cancer-Kinase/protease
Manufacturer - Targets
EGFR
Shipping Temperature
Room temperature
Molecular Weight
399.47
Product Description
Erlotinib-d6 (CP-358774 D6) is a deuterium labeled Erlotinib (CP-358774). Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR[1]. Erlotinib-d6 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Manufacturer - Research Area
Cancer
Solubility
10 mM in DMSO
Manufacturer - Pathway
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close